Tilray® announces agreement with grow pharma to import and distribute medical cannabis products in the united kingdom

Nanaimo, british columbia--(business wire)--tilray inc. (nasdaq: tlry), a global pioneer in cannabis research, cultivation, production, and distribution, today announced it has established an agreement with grow pharma to import and distribute tilray's medical cannabis products into the united kingdom (uk). this agreement allows tilray to provide authorized uk patients in need with a locally maintained supply of medical cannabis solutions. tilray expects to have a range of gmp-certified, medica
TLRY Ratings Summary
TLRY Quant Ranking